These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 17403612

  • 1. TRAIL signalling: decisions between life and death.
    Falschlehner C, Emmerich CH, Gerlach B, Walczak H.
    Int J Biochem Cell Biol; 2007; 39(7-8):1462-75. PubMed ID: 17403612
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TRAIL and cancer therapy.
    Kruyt FA.
    Cancer Lett; 2008 May 08; 263(1):14-25. PubMed ID: 18329793
    [Abstract] [Full Text] [Related]

  • 9. Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis.
    Secchiero P, Zauli G.
    Curr Opin Hematol; 2008 Jan 08; 15(1):42-8. PubMed ID: 18043245
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response.
    Chen LH, Jiang CC, Kiejda KA, Wang YF, Thorne RF, Zhang XD, Hersey P.
    Carcinogenesis; 2007 Nov 08; 28(11):2328-36. PubMed ID: 17652336
    [Abstract] [Full Text] [Related]

  • 12. TRAIL receptor signaling and therapeutics.
    Abdulghani J, El-Deiry WS.
    Expert Opin Ther Targets; 2010 Oct 08; 14(10):1091-108. PubMed ID: 20819019
    [Abstract] [Full Text] [Related]

  • 13. Role of IG20 splice variants in TRAIL resistance.
    Prabhakar BS, Mulherkar N, Prasad KV.
    Clin Cancer Res; 2008 Jan 15; 14(2):347-51. PubMed ID: 18223207
    [Abstract] [Full Text] [Related]

  • 14. The TRAIL apoptotic pathway in cancer onset, progression and therapy.
    Johnstone RW, Frew AJ, Smyth MJ.
    Nat Rev Cancer; 2008 Oct 15; 8(10):782-98. PubMed ID: 18813321
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC, Chen LH, Gillespie S, Kiejda KA, Mhaidat N, Wang YF, Thorne R, Zhang XD, Hersey P.
    Cancer Res; 2007 Jun 15; 67(12):5880-8. PubMed ID: 17575157
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies.
    MacFarlane M, Kohlhaas SL, Sutcliffe MJ, Dyer MJ, Cohen GM.
    Cancer Res; 2005 Dec 15; 65(24):11265-70. PubMed ID: 16357130
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.